Odefsey 200 mg

Odefsey 200 mg tablets contain emtricitabine, a medication used in HIV treatment. This oral tablet is manufactured by Gilead Sciences Canada Inc. and is available in a 30-tablet pack.

Odefsey 200 mg tablets are primarily used as part of a combination therapy for HIV-1 infection in adults and children weighing at least 35 kg. Emtricitabine, the active ingredient, is a nucleoside analog reverse transcriptase inhibitor (NRTI) that helps manage HIV by reducing the amount of virus in the body. This medication is often prescribed alongside other antiretroviral drugs to achieve optimal treatment outcomes.

Common effects of Odefsey 200 mg tablets may include headache, diarrhea, nausea, and dizziness. Some individuals might experience changes in body fat distribution, such as increased abdominal fat or loss of fat in the legs, arms, and face. It's important to discuss any persistent or severe side effects with a healthcare provider.

Odefsey 200 mg tablets should be handled with care, especially if you have a history of kidney problems, as emtricitabine is primarily excreted by the kidneys. It is crucial to follow the prescribed dosage and not to share this medication with others. Always store the tablets in a cool, dry place away from direct sunlight and out of reach of children.

Odefsey 200 mg tablets may interact with other medications, including certain antiretrovirals, antibiotics, and antifungals. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be moderated, as it may exacerbate some side effects.